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Abstract 
Background: BAHD acyltransferases, named after the first four biochemically characterized enzymes of the group, 
are plant‑specific enzymes that catalyze the transfer of coenzyme A‑activated donors onto various acceptor mol‑
ecules. They are responsible for the synthesis in plants of a myriad of secondary metabolites, some of which are ben‑
eficial for humans either as therapeutics or as specialty chemicals such as flavors and fragrances. The production of 
pharmaceutical, nutraceutical and commodity chemicals using engineered microbes is an alternative, green route to 
energy‑intensive chemical syntheses that consume petroleum‑based precursors. However, identification of appropri‑
ate enzymes and validation of their functional expression in heterologous hosts is a prerequisite for the design and 
implementation of metabolic pathways in microbes for the synthesis of such target chemicals.
Results: For the synthesis of valuable metabolites in the yeast Saccharomyces cerevisiae, we selected BAHD acyltrans‑
ferases based on their preferred donor and acceptor substrates. In particular, BAHDs that use hydroxycinnamoyl‑CoAs 
and/or benzoyl‑CoA as donors were targeted because a large number of molecules beneficial to humans belong 
to this family of hydroxycinnamate and benzoate conjugates. The selected BAHD coding sequences were synthe‑
sized and cloned individually on a vector containing the Arabidopsis gene At4CL5, which encodes a promiscuous 
4‑coumarate:CoA ligase active on hydroxycinnamates and benzoates. The various S. cerevisiae strains obtained for 
co‑expression of At4CL5 with the different BAHDs effectively produced a wide array of valuable hydroxycinnamate 
and benzoate conjugates upon addition of adequate combinations of donors and acceptor molecules. In particular, 
we report here for the first time the production in yeast of rosmarinic acid and its derivatives, quinate hydroxycinna‑
mate esters such as chlorogenic acid, and glycerol hydroxycinnamate esters. Similarly, we achieved for the first time 
the microbial production of polyamine hydroxycinnamate amides; monolignol, malate and fatty alcohol hydroxycin‑
namate esters; tropane alkaloids; and benzoate/caffeate alcohol esters. In some instances, the additional expression 
of Flavobacterium johnsoniae tyrosine ammonia‑lyase (FjTAL) allowed the synthesis of p‑coumarate conjugates and 
eliminated the need to supplement the culture media with 4‑hydroxycinnamate.
© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
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publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Background
Chemical synthesis from non-renewable resources is the 
route most employed for production of chemicals used in 
both the pharmaceutical and flavor and fragrance indus-
tries. Several alternatives have emerged to limit the use of 
petroleum-based chemicals and to develop environmen-
tally friendly methods through decreasing solvent utiliza-
tion and reducing the carbon footprint of manufacturing 
processes. An example of such an alternative is biologi-
cal synthesis via the use of engineered microbes for the 
production of fine and specialty chemicals. Because these 
processes consume renewable lignocellulosic biomass as 
a carbon source, they have reduced need for toxic chemi-
cals and also offers consistent quality, scalability, simple 
extraction procedures and the potential for higher syn-
thesis efficiency [1, 2]. In addition, biological synthesis 
could expand the chemical diversity of natural products, 
the structural complexity of which is sometimes chal-
lenging to achieve using multistep chemical synthesis [3]. 
In this area, the industrial microorganism S. cerevisiae 
is a powerful host platform for the biosynthesis of plant 
secondary metabolites such as beta-carotene, amorpha-
diene, valencene, casbene, cubebol, linalool, patchoulol, 
resveratrol and vanillin. This is due to its food-grade sta-
tus, its advantages in the expression of complex meta-
bolic pathways, extensive knowledge regarding its use in 
large-scale production, the availability of genetic tools, 
and its biodiversity [4].
BAHD acyltransferases are plant enzymes that cata-
lyze the transfer of coenzyme A-activated donors—
which include acetyl-CoA, β-phenylalanine-CoA, 
malonyl-CoA, tiglyl-CoA, anthraniloyl-CoA, benzoyl-
CoA and (hydroxy)cinnamoyl-CoA—onto several 
types of acceptor molecules [5]. BAHDs catalyze O- or 
N-acylation of acceptors by acylating their hydroxyl 
(OH) or amine (NH2) groups, respectively, with CoA 
donors (Fig.  1). In plants, these enzymes participate in 
the synthesis of a wide range of polymers and second-
ary metabolites such as cutin, suberin, lignin, volatiles, 
pigments and defense compounds [5]. Furthermore, 
several BAHD acyltransferases catalyze the forma-
tion of metabolites beneficial for human health, which 
has prompted their use as biocatalysts in engineered 
microbes. For example, engineered Escherichia coli 
strains have been developed to express BAHDs such as 
hydroxycinnamoyl-CoA:quinate transferases (HQT) 
for the synthesis of the antioxidant chlorogenic acid [6, 
7]; hydroxycinnamoyl-CoA:hydroxyphenyllactate trans-
ferases for the production of rosmarinic acid [8–10]; 
hydroxycinnamoyl-CoA:glycerol transferase for the 
synthesis of the water-soluble antioxidants hydroxy-
cinnamate glycerol esters [11] and hydroxycinnamoyl/
benzoyl-CoA:anthranilate transferase (HCBT) for the 
production of therapeutic benzoyl and hydroxycinnamoyl 
anthranilates [12]. To our knowledge, the use of yeast 
strains engineered for the expression of BAHD acyltrans-
ferases has not been reported, except for the synthesis of 
hydroxycinnamoyl anthranilates using either HCBT or 
promiscuous hydroxycinnamoyl-CoA:shikimate trans-
ferases [13–16].
Hydroxycinnamic acids such as p-coumaric acid, caf-
feic acid, ferulic acid and sinapic acid possess antioxi-
dant properties, antimicrobial activities and have been 
implicated in the prevention of cardiovascular diseases 
and cancer [17]. Importantly, the pharmacokinetics and 
bioavailability of hydroxycinnamic acids, as well as their 
antimicrobial activity, are highly dependent on their 
chemical structures and the types of molecules to which 
they are conjugated [17, 18]. Moreover, certain benzo-
ate conjugates are also used for their health benefits and 
therapeutic effects [19, 20], whereas benzoate alcohol 
esters are widely used as flavoring agents in the food and 
cosmetic industries [21, 22].
In this study, we investigated the potential of 10 mem-
bers of the BAHD acyltransferase family for the pro-
duction of diverse hydroxycinnamate and benzoate 
conjugates in S. cerevisiae after feeding with compatible 
acceptor molecules. These enzymes were selected based 
on their capacity to use hydroxycinnamoyl-CoAs and/
or benzoyl-CoAs as donor molecules and their affinity 
for structurally divergent acceptors. We have previously 
Conclusion: We demonstrate in this study the effectiveness of expressing members of the plant BAHD acyltrans‑
ferase family in yeast for the synthesis of numerous valuable hydroxycinnamate and benzoate conjugates.
Keywords: Yeast, BAHD, Antioxidant, Therapeutics, Flavors and fragrances, CAPE
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Amide bond
Fig. 1 Mechanism of acylation catalyzed by BAHD acyltransferases. 
Acyl donors are activated upon esterification of their carboxylic 
group (COOH) with coenzyme A (CoA). BAHD acyltransferases using 
4‑hydroxycinnamoyl‑CoAs (R = 4‑hydroxystyrene) and benzoyl‑CoAs 
(R = benzene) as donors were used for this study. R’ = BAHD acceptor
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reported on a two-gene strategy for co-expression in 
S. cerevisiae of Arabidopsis (Arabidopsis thaliana) 
4-coumarate:CoA ligase 5 (4CL5) and HCBT for the syn-
thesis of hydroxycinnamoyl anthranilates upon feeding 
with hydroxycinnamates and anthranilate [13]. We also 
recently showed evidence that 4CL5 can accept benzoic 
acid as a substrate, which enabled the production of ben-
zoyl anthranilates when co-expressed with HCBT [14]. 
Here, taking advantage of 4CL5 substrate’s promiscuity, 
several BAHD acyltransferases were selected and co-
expressed with 4CL5 in an attempt to synthesize in yeast 
novel hydroxycinnamate and benzoate esters and amides. 
Furthermore, although the yields of product formation 
were typically two to fivefold lower compared to those 
achieved with p-coumarate feedings, additional expres-
sion of tyrosine ammonia-lyase from Flavobacterium 
johnsoniae (FjTAL), which converts tyrosine into p-cou-
marate [23], enabled the synthesis of p-coumarate esters 
and amides directly from the endogenous tyrosine pool.
Results and discussion
Synthesis of rosmarinic acid and analogues
Rosmarinic acid (RA), a caffeate ester of 3,4-dihydroxy-
phenyllactate, and its analogues, are strong antioxidants 
with several beneficial properties for human health 
[24]. The RA synthase LaAT1 from lavender (Lavan-
dula angustifolia), a member of the BAHD family, was 
selected for expression in yeast because of its substrate 
promiscuity towards various donors and acceptors [25]. 
A S. cerevisiae strain co-expressing 4CL5 and LaAT1 
was generated. Growing this strain in the presence of 
4-hydroxyphenyllactate (LaAT1’s preferred acceptor), 
p-coumarate, caffeate and ferulate resulted in the pro-
duction of p-coumaroyl 4′-hydroxyphenyllactate, caffeoyl 
4′-hydroxyphenyllactate (isorinic acid) and feruloyl 
4′-hydroxyphenyllactate, respectively (Fig.  2a–c). Simi-
larly, feeding the strain with 3,4-dihydroxyphenyllactate 
as the acceptor and p-coumarate, caffeate and ferulate 
as donors resulted in the production of p-coumaroyl 
3′,4′-dihydroxyphenyllactate, caffeoyl 3′,4′-dihydroxy-
phenyllactate (RA) and feruloyl 3′,4′-dihydroxyphenyllac-
tate, respectively (Fig. 2d–f). Quantification of RA using 
an authentic standard showed that the culture medium 
contained 429  ±  81  µM (or 154  mg/L) (Fig.  2g). None 
of these products were observed in the culture medium 
of a control strain expressing 4CL5 alone and fed with 
the same precursors (data not shown). To our knowl-
edge, this is the first report of RA biosynthesis in yeast. 
Moreover, considering the substrate promiscuity of 
LaAT1 [25], additional RA analogues would likely be 
produced by supplying the culture medium with alter-
native donors and acceptors. Such substrate flexibility 
has been explored for RA synthase from Coleus blumei 
and allowed biosynthesis of 13 RA analogues in E. coli 
[10]. Heterelogous pathways for the synthesis of the two 
acceptors, 4-hydroxyphenyllactate and 3,4-dihydroxy-
phenyllactate, from an inexpensive renewable carbon 
source has already been demonstrated in E. coli [8, 9] 
and could be implemented in yeast for sustainable and 
economical biosynthesis. We also demonstrated that 
expression of tyrosine ammonia-lyase (FjTAL) in addi-
tion to 4CL5 and LaAT1 results in the production of 
p-coumaroyl 4′-hydroxyphenyllactate when the FjTAL-
4CL5-LaAT1 strain is fed with only 4-hydroxyphenyl-
lactate (Additional file 1: Figure S1A). This result shows a 
potential in yeast for producing hydroxycinnamates more 
sustainably and directly by using endogenous tyrosine as 
a precursor pool.
Synthesis of chlorogenic acid
Caffeoyl quinate (chlorogenic acid) and its derivatives 
have several beneficial properties for human health [6, 7, 
26]. NtHQT, a BAHD enzyme from tobacco (Nicotiana 
tabacum), was selected for the synthesis of coumaroyl 
quinate and chlorogenic acid in S. cerevisiae because it 
uses both p-coumaroyl-CoA and caffeoyl-CoA as donors 
and quinate as its acceptor [27]. We confirmed that feed-
ing a strain expressing 4CL5 and NtHQT with quinate 
and p-coumarate or caffeate resulted in the production 
of the two target metabolites, namely coumaroyl quinate 
and chlorogenic acid (Additional file  1: Figure S2). The 
subsequent quantification of chlorogenic acid using an 
authentic standard showed that the culture medium con-
tained 1.43 ± 0.21 µM (or 506 µg/L). To our knowledge, 
this is the first example of chlorogenic acid biosynthesis 
in yeast. Because of the conservation of the shikimate 
pathway between bacteria and yeast, engineering strate-
gies for accumulation of quinate described in E. coli [28] 
could be easily transferred to our 4CL5-NtHQT yeast 
strain to achieve chlorogenic acid synthesis without feed-
ing quinate.
Synthesis of glycerol hydroxycinnamates
Glycerol hydroxycinnamate esters have higher water 
solubility than non-conjugated hydroxycinnamates and 
several of these esters, such as feruloyl glycerol conju-
gates, have antioxidant capacities and neuroprotective 
effects [29, 30]. Hydroxycinnamoyl-CoA:glycerol trans-
ferase OsHCT4 from rice (Oryza sativa) was selected for 
the synthesis of hydroxycinnamoyl glycerol conjugates 
in yeast [11]. Because OsHCT4 uses p-coumaroyl-CoA, 
feruloyl-CoA and caffeoyl-CoA as donors, a strain co-
expressing 4CL5 and OsHCT4 was generated and fed 
with glycerol and either p-coumarate, ferulate or caffeate. 
For these cultures, analysis of the medium revealed the 
presence of p-coumaroyl glycerol, feruloyl glycerol and 
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Fig. 2 Production of rosmarinic acid and analogues in yeast. Representative LC–MS chromatograms obtained from analysis of the culture medium 
of a S. cerevisiae strain expressing 4CL5 and LaAT1 are shown. The strain was fed with 4‑hydroxyphenyllactate and p‑coumarate, caffeate and ferulate 
for the synthesis of p‑coumaroyl 4′‑hydroxyphenyllactate (a), caffeoyl 4′‑hydroxyphenyllactate (b) and feruloyl 4′‑hydroxyphenyllactate (c), respec‑
tively. Feeding the strain with 3,4‑dihydroxyphenyllactate and p‑coumarate, caffeate and ferulate allowed the synthesis of p‑coumaroyl 3′,4′‑dihy‑
droxyphenyllactate (d), rosmarinic acid (e) and feruloyl 3′,4′‑dihydroxyphenyllactate (f), respectively. The LC–MS chromatogram of a solution of 
authentic rosmarinic acid is also shown (g)
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caffeoyl glycerol, respectively (Fig.  3a–c). Interestingly, 
and only in the case of caffeate feeding, a compound with 
a m/z value matching that of trisubstituted glycerol (i.e., 
1,2,3-tricaffeoyl glycerol) was also detected (Fig.  3d). 
None of these products were observed in the culture 
medium of a strain expressing 4CL5 alone and fed with 
the same precursors (data not shown). These experi-
ments are the first example of synthesis of hydroxycin-
namate glycerol conjugates in yeast. Finally, using its 
endogenous glycerol pool, a strain expressing FjTAL, 
4CL5 and OsHCT4 produced p-coumaroyl glycerol with-
out the addition of any precursors to the culture medium 
(Additional file 1: Figure S1B).
Synthesis of polyamine hydroxycinnamates
Multiple studies have reported on the beneficial prop-
erties of hydroxycinnamate amides of polyamines. For 
example, spermidine hydroxycinnamate conjugates 
have antioxidant [31, 32], antibacterial [33], antiviral 
[34], insecticidal [35] and antiparasitic [36] activities. 
Other studies have demonstrated the inhibitory activ-
ity of polysubstituted p-coumaroyl polyamines on 
brain transporters for which a genetic polymorphism 
is associated with psychological disorders [37, 38]. For 
this experiment, we selected the BAHDs p-coumaroyl-
CoA:spermidine (AtSCT) and sinapoyl-CoA:spermidine 
(AtSDT) transferases from Arabidopsis [39], and p-cou-
maroyl-CoA:agmatine transferase (HvACT) from barley 
(Hordeum vulgare) [40]. Consistent with the properties of 
both AtSCT and AtSDT to catalyze the transfer of two 
hydroxycinnamate moieties onto spermidine [39], feed-
ing with spermidine and p-coumarate or sinapate strains 
co-expressing 4CL5 with AtSCT or AtSDT resulted in 
the synthesis of dicoumaroyl and disinapoyl spermidine 
conjugates, respectively (Fig.  4a, b). In particular, a sin-
gle new liquid chromatography-mass spectrometry (LC–
MS) peak with a m/z value corresponding to 438.2395 
[M  +  H]+ was detected in the medium of the 4CL5-
AtSCT strain (Fig. 4a), suggesting the presence of N1,N8-
dicoumaroyl spermidine as previously observed in  vitro 
[39]. In the case of the 4CL5-AtSDT strain, LC–MS anal-
ysis of the culture medium showed a double LC–MS peak 
with a m/z value corresponding to 558.2808 [M +  H]+ 
(Fig.  4b), suggesting the presence of another disinapoyl 
spermidine isomer (i.e. N1,N4-disinapoyl spermidine or 
N4,N8-disinapoyl spermidine) in addition to the previ-
ously characterized AtSDT product, N1,N8-disinapoyl 
spermidine [39]. The presence of a monosubstituted 
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Fig. 3 Production of glycerol hydroxycinnamates in yeast. Representative LC–MS chromatograms obtained from analysis of the culture medium 
of a S. cerevisiae strain expressing 4CL5 and OsHCT4 are shown. The strain was fed with glycerol and p‑coumarate, ferulate and caffeate for the 
synthesis of p‑coumaroyl glycerol (a), feruloyl glycerol (b) and caffeoyl glycerol (c), respectively. Structures corresponding to 2‑O‑hydroxycinnamoyl‑
glycerides are represented as previously determined [11]. A compound with a mass matching that of 1,2,3‑tricaffeoyl glycerol was also detected in 
the case of caffeate feedings (d)
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Fig. 4 Production of polyamine hydroxycinnamates in yeast. Representative LC–MS chromatograms obtained from analysis of the culture medium 
of S. cerevisiae strains expressing 4CL5 and AtSCT (a, c–f) or 4CL5 and AtSDT (b, g, h) are shown. The 4CL5‑AtSCT strain was fed with spermidine and 
p‑coumarate, ferulate or sinapate for the synthesis of dicoumaroyl spermidine (a) p‑coumaroyl spermidine (c), feruloyl spermidine (d), sinapoyl sper‑
midine (e) and diferuloyl spermidine (f). The 4CL5‑AtSDT strain was fed with sinapate and spermidine, putrescine and spermine for the synthesis 
of disinapoyl spermidine (b) sinapoyl putrescine (g) and disinapoyl spermine (h), respectively. Structures in a and b are represented as previously 
determined in [39] whereas other structures are arbitrarily shown with substitutions of the polyamines on N1, N8 (c–g) and N1, N12 (h)
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spermidine (i.e., p-coumaroyl spermidine) was also 
observed in the culture medium of the 4CL5-AtSCT 
strain but not in that of the 4CL5-AtSDT strain (Fig. 4c). 
Experiments exploring the substrate promiscuity of 
AtSDT and AtSCT were conducted to produce additional 
polyamine hydroxycinnamates. Feeding the 4CL5-AtSCT 
strain with spermidine and ferulate or sinapate success-
fully enabled the biosynthesis of feruloyl spermidine and 
sinapoyl spermidine, respectively (Fig.  4d, e). Moreover, 
a double LC–MS peak with a m/z value matching that 
of diferuloyl spermidine was detected when ferulate was 
supplied (Fig. 4f ), but the exact identities of the two iso-
mers was not determined. Next, feeding the 4CL5-AtSDT 
strain with sinapate and putrescine or spermine resulted 
in the synthesis of sinapoyl putrescine and disinapoyl 
spermine, respectively (Fig.  4g, h). These results show 
that the substrate flexibility of the two enzymes toward 
both donors and acceptors can be exploited for the syn-
thesis of diverse polyamine hydroxycinnamates. This 
is the first report of biological synthesis of polyamine 
hydroxycinnamates in microbes, and our results show the 
potential for the production of disubstituted polyamine 
conjugates. We also demonstrated that co-expression of 
FjTAL with 4CL5 and AtSCT resulted in the production 
of N1,N8-dicoumaroyl spermidine without the addition of 
any precursors to the culture medium (Additional file 1: 
Figure S1C), providing a potential route to sustainable 
synthesis of such compounds. This indicates that sper-
midine pools in S. cerevisiae are sufficient for such bio-
synthetic approaches. In that respect, recently developed 
engineering strategies for enhancing spermidine content 
in yeast could be applied to our strain [41]. Lastly, our list 
of microbially produced polyamine hydroxycinnamates 
was extended after a strain co-expressing FjTAL, 4CL5 
and HvACT and fed with agmatine was able to produce 
p-coumaroyl agmatine (Additional file 1: Figure S1D).
Synthesis of monolignol hydroxycinnamates
Monolignol hydroxycinnamates belong to another class 
of hydroxycinnamate ester conjugates with beneficial 
pharmacological properties. For example, coniferyl fer-
ulate has antibacterial activity, antioxidant and anti-
Alzheimer properties, and it was also shown to have a 
potential role in reversing multidrug resistance mech-
anisms acquired by tumor cells [42–44]. Feruloyl-
CoA:monolignol transferase (AsFMT) from Chinese 
angelica (Angelica sinensis) is a BAHD enzyme involved 
in the synthesis of coniferyl ferulate by coupling feruloyl-
CoA to the monolignol coniferyl alcohol [45]. A S. cer-
evisiae strain that co-expressed 4CL5 with AsFMT was 
generated and grown in the presence of ferulate and 
coniferyl alcohol for the synthesis of coniferyl ferulate. 
Interestingly, using LC–MS analysis and an authentic 
standard for comparison, we observed that coniferyl 
ferulate was effectively produced by the yeast strain 
(Fig. 5a–b) but remained exclusively intracellular. This is 
the first successful attempt at producing coniferyl feru-
late in microbes. To facilitate its purification and reduce 
production costs, it would be useful to evaluate other 
hosts for their capability to synthesize and excrete this 
valuable product. In this respect, several strains of E. coli 
have been engineered for the production of p-coumaryl 
alcohol via p-coumaroyl-CoA and could become suitable 
hosts [46, 47].
Synthesis of malate hydroxycinnamates
Malate hydroxycinnamates are another group of hydrox-
ycinnamate esters with potential beneficial properties for 
human health, as exemplified by caffeoyl malate (phaselic 
acid), which possesses anti-inflammatory activities [48]. 
Hydroxycinnamoyl-CoA:malate transferase from red clo-
ver (Trifolium pratense) (TpHCT2) was selected for the 
production of malate hydroxycinnamates in yeast [49]. 
A S. cerevisiae strain co-expressing 4CL5 and TpHCT2 
was fed with malate and p-coumarate or caffeate. LC–MS 
analysis of the culture medium showed the presence of 
peaks corresponding to p-coumaroyl malate and phaselic 
acid, respectively (Fig. 6a, b). These LC–MS peaks were 
absent from control cultures of a strain expressing 4CL5 
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Fig. 5 Production of coniferyl ferulate in yeast. A representative 
LC–MS chromatogram of a hexane extract of isolated S. cerevisiae cells 
expressing 4CL5 and AsFMT and previously grown in the presence of 
ferulate and coniferyl alcohol is shown (a). Identification of intracellu‑
lar coniferyl ferulate was made by comparison with the LC–MS profile 
of a solution of authentic coniferyl ferulate (b)
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alone and fed with the same precursors (data not shown). 
This is the first example of the production of malate 
hydroxycinnamates in microbes, and such synthesis 
could theoretically be achieved sustainably considering 
existing engineering methods used to obtain high titers 
of malate in yeast [50]. Concerning the de novo synthesis 
of hydroxycinnamate moieties, we also show that expres-
sion of FjTAL in the 4CL5-TpHCT2 strain can sustain the 
synthesis of p-coumaroyl malate without an external sup-
ply of p-coumarate (Additional file 1: Figure S1E).
Synthesis of alkyl hydroxycinnamates
Alkyl hydroxycinnamates such as hydroxycinnamate 
esters of fatty alcohols are lipophilic antioxidants that 
can efficiently inhibit the growth of tumor cells [51, 52]. 
Hydroxycinnamoyl-CoA:fatty alcohol transferase from 
Arabidopsis (AtHHT3), which accepts various medium 
chain fatty alcohols as substrates, was selected for the 
synthesis of dodecyl hydroxycinnamates [53]. In par-
ticular, a S. cerevisiae strain co-expressing 4CL5 with 
AtHHT3 and fed with 1-dodecanol and p-coumarate, 
caffeate or ferulate produced the potent antioxidants 
dodecyl p-coumarate, dodecyl caffetae and dodecyl feru-
late, respectively (Fig.  7a–c). These alkyl hydroxycinna-
mates were not detected in cultures of a control strain 
expressing 4CL5 alone and fed with hydroxycinnamates 
and 1-dodecanol (data not shown). The microbial synthe-
sis of alkyl hydroxycinnamates has never been reported 
and engineering strategies used for the production of 
fatty alcohols could be leveraged for their de novo syn-
thesis [54, 55]. Moreover, using a strain that co-express 
FjTAL with 4CL5 and AtHHT3, we achieved the produc-
tion of dodecyl p-coumarate by supplying only 1-dode-
canol to the culture medium (Additional file 1: Fig. S1F).
Synthesis of cinnamoyl and benzoyl tropane analogues
Tropane alkaloids, such as cinnamate and benzoate esters 
of tropane skeletons, are of considerable interest due to 
their wide range of biological activities, and some are 
commonly employed in the pharmaceutical industry [56, 
57]. Cocaine synthase (EcCS) from coca (Erythroxylum 
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Fig. 6 Production of malate hydroxycinnamates in yeast. Representa‑
tive LC–MS chromatograms obtained from analysis of the culture 
medium of a S. cerevisiae strain expressing 4CL5 and TpHCT2 are 
shown. The strain was fed with malate and p‑coumarate or caffeate 
for the synthesis of p‑coumaroyl malate (a) and phaselic acid (b), 
respectively
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Fig. 7 Production of dodecyl hydroxycinnamates in yeast. Rep‑
resentative LC–MS chromatograms obtained from analysis of the 
culture medium of a S. cerevisiae strain expressing 4CL5 and AtHHT3 
are shown. The strain was fed with 1‑dodecanol and p‑coumarate, 
caffeate or ferulate for the synthesis of dodecyl p‑coumarate (a), 
dodecyl caffeate (b) and dodecyl ferulate (c), respectively
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coca) catalyzes the transfer of both cinnamoyl-CoA and 
benzoyl-CoA onto 2-carbomethoxy-3β-tropine for the 
synthesis of the tropane alkaloids cinnamoylcocaine and 
cocaine, respectively [58]. Because we previously demon-
strated the activity of 4CL5 towards cinnamate and ben-
zoate in yeast [14], and considering that EcCS was also 
shown to use 3β-tropine as an acceptor in vitro [58], we 
generated a S. cerevisiae strain that co-express 4CL5 and 
EcCS for the synthesis of the tropane alkaloids cinnamoyl 
3β-tropine and benzoyl 3β-tropine (tropacocaine). By 
comparison with an authentic standard, LC–MS analy-
sis identified cinnamoyl 3β-tropine (9.58 ±  1.06  µM or 
2.6 mg/L) in the culture medium of the 4CL5-EcCS strain 
grown in the presence of cinnamate and 3β-tropine 
(Fig. 8a, b). Similarly, benzoyl 3β-tropine was detected in 
the culture medium of the 4CL5-EcCS strain cultivated 
with the precursors benzoate and 3β-tropine (Fig.  8c). 
None of these products were detected in control cultures 
of a strain expressing 4CL5 alone and fed with the same 
precursors (data not shown). Nevertheless, further inves-
tigation will be needed since the detection of double LC–
MS peaks strongly suggests the presence of two isomers 
for each product, possibly due to the isomerization of 
3β-tropine in the culture medium. To our knowledge, this 
is the first report on the synthesis of tropane alkaloids in 
microbes, and it would be interesting to investigate the 
substrate flexibility of EcCS for the synthesis of phar-
macologically valuable cinnamoyl and benzoyl tropane 
analogues [20]. As future work, the plant β-oxidative 
pathway of benzoic acid biosynthesis could be imported 
into yeast for the synthesis of benzoyl-CoA from pheny-
lalanine [59], as well as the metabolic engineering strate-
gies already established in hairy root culture systems for 
the synthesis of tropane moieties from arginine [60].
Synthesis of benzoate alcohol esters and caffeate 
phenethyl ester (CAPE)
Benzoate alcohol esters are widely used as flavoring 
agents in foods and cosmetics as well as in hygiene and 
pharmaceutical products [21, 22]. Benzoyl-CoA:benzyl 
alcohol/phenylethanol benzoyltransferase (BPBT), a 
BAHD enzyme from petunia (Petunia x hybrida), uses 
benzoyl-CoA as a donor and various alcohols as accep-
tors for the formation of benzoate alcohol esters [61]. A 
S. cerevisiae strain was generated for the co-expression 
of 4CL5 and BPBT. Based on the substrate preference 
of BPBT observed in  vitro [61], our 4CL5-BPBT strain 
was fed with benzoic acid in combination with ethanol, 
butanol, isopentanol or 2-phenylethanol. By comparison 
with the elution of authentic standards, LC–MS analy-
sis of the culture media showed the presence of ethyl 
benzoate (1.39  ±  0.40  µM or 209  µg/L), butyl benzo-
ate (2.65  ±  0.69  µM or 471  µg/L), isopentyl benzoate 
(2.50  ±  0.50  µM or 481  µg/L) and phenethyl benzoate 
(7.80 ± 1.73 µM or 1763 µg/L), respectively (Fig. 9a–h). 
Moreover, caffeate phenethyl ester (CAPE) is a bioac-
tive compound that possesses antimicrobial, antioxidant, 
anti-inflammatory and cytotoxic properties [62, 63]. 
Therefore, the capacity of BPBT to accept 2-phenyle-
thanol as a substrate is of particular interest toward the 
biological synthesis of CAPE and its derivatives, espe-
cially because its production using chemical synthesis 
or its purification from natural sources (e.g., honeybee 
hives) are low-yielding procedures [64]. Feeding our 
4CL5-BPBT strain with caffeate and 2-phenylethanol 
resulted in successful synthesis of CAPE (1.61 ± 0.23 nM 
or 457 ng/L), which was identified by LC-MS analysis of 
the culture medium (Fig. 9i–j). Although several BAHDs 
acyltransferases similar to BPBT have been shown to 
transfer benzoyl-CoA onto 2-phenylethanol [65, 66], the 
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Fig. 8 Production of tropane alkaloids in yeast. Representative LC–
MS chromatograms obtained from analysis of the culture medium of 
a S. cerevisiae strain expressing 4CL5 and EcCS are shown. The strain 
was fed with 3β‑tropine and cinnamate or benzoate for the synthesis 
of cinnamoyl 3β‑tropine (a) and tropacocaine (c), respectively. Note 
the double LC–MS peaks suggesting the presence of two isomers for 
each product. The LC–MS chromatogram of a solution of authentic 
cinnamoyl 3β‑tropine is also shown (b)
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pRS423 vector was used for the expression of FjTAL 
under the control of the constitutive promoter PTDH3. 
The S. cerevisiae pad1 knockout (MATa his3∆1 leu2∆0 
met15∆0 ura3∆0 ∆pad1, ATCC 4005833) [69] was 
transformed using the Frozen-EZ Yeast Transformation 
II Kit™ (Zymo Research Corporation, Irvine, CA) and 
selected on solid medium containing yeast nitrogen base 
(YNB) without amino acids (Difco 291940; Difco, Detroit, 
MI) supplemented with 3% glucose and 1X dropout-ura-
cil (CSM-ura) or 1X dropout-uracil-histidine (CSM-ura-
his) (Sunrise Science Products, San Diego, CA).
Construction of plasmids
A description of the plasmids used in this study is pro-
vided in Table 1. For the construction of the pDRf1-4CL5-
DsRed vector, a red fluorescent protein (DsRed) dropout 
cassette sequence (kindly provided by Chris Ander-
son’s lab, UC Berkeley) was synthesized with flanking 
sequences (Genescript, Piscataway, NJ; Additional file 1: 
Data S1). It contains at the 5′-end the 18-bp sequence 
located upstream of the EcoRI site in pDRf1-4CL5-GW 
[13], followed by an EcoRI restriction site, the Gateway 
recombination site attB1 and a PmlI restriction site. At 
the 3′-end, it contains a PmlI restriction site, followed 
by the Gateway recombination site attB2, a PstI restric-
tion site and the 15-bp sequence located upstream of the 
PstI site in pDRf1-4CL5-GW. This sequence was ampli-
fied by PCR using the oligonucleotides DsRed-dropout-
fw and DsRed-dropout-rv (Additional file  1: Table S2) 
and inserted by In-Fusion cloning (Clonetech, Mountain 
View, CA) into a pDRf1-4CL5-GW vector digested with 
EcoRI and PstI to remove the Gateway cassette and yield 
the pDRf1-4CL5-DsRed vector. BAHD acyltransferase 
nucleotide sequences were codon-optimized for expres-
sion in S. cerevisiae using an empirically derived codon 
usage table. Codon optimization, including restriction 
site removal, and oligo design (150 mers) were performed 
using GeneDesign [70]. Oligonucleotides were pooled for 
synthesis using acoustic deposition (Labcyte Echo 550), 
and synthesis was performed at the Joint Genome Insti-
tute using a two-step polymerase chain assembly (PCA) 
approach in 2  μL final volume as previously described 
[71]. PCA products were purified by gel excision and 
cloned into a PmlI-digested pDRf1-4CL5-DsRed vec-
tor using Gibson assembly to generate the pDRf1-4CL5-
BAHDs vectors. Plating and picking were performed 
(See figure on next page.) 
Fig. 9 Production of benzoate alcohol esters and CAPE in yeast. Representative LC–MS chromatograms of hexane extracts of culture media of a S. 
cerevisiae strain expressing 4CL5 and BPBT are shown. The strain was fed with benzoate and ethanol, butanol, isopentanol or 2‑phenylethanol for 
the synthesis of ethyl benzoate (a), butyl benzoate (c), isopentyl benzoate (e) and phenethyl benzoate (g), respectively. Identification of the different 
benzoate alcohol esters was made by comparison with the LC–MS profiles of authentic standards (b, d, f, h). Similarly, feeding the strain with caffeate 
and 2‑phenylethanol allowed the synthesis of CAPE (i) by comparison with the LC–MS profile of an authentic CAPE standard (j)
use of hydoxycinnamoyl-CoA donors (e.g., caffeoyl-CoA) 
by these enzymes has never been reported and could 
enable the biological synthesis of valuable hydroxycinna-
mate phenethyl esters. Taking advantage of existing engi-
neering strategies that yield high titers of alcohols and 
2-phenylethanol should enable the economical synthesis 
of benzoate alcohol esters and CAPE in yeast [67, 68].
Conclusions
This study illustrates the potential of using BAHD acyl-
transferases from plants and S. cerevisiae as an expression 
host for the biological synthesis of valuable molecules 
that are usually produced from petrochemicals or found 
at very low concentration in plant extracts. In particular, 
expression of BAHD acyltransferases that use hydoxycin-
namoyl-CoA and benzoyl-CoA allowed the synthesis of 
more than 30 different compounds which have applica-
tions across diverse sectors such as human health prod-
ucts and the flavor and fragrance industry. Exploring the 
substrate promiscuity of these BAHDs could consider-
ably expand the number of molecules produced. Moreo-
ver, the use of BAHDs activity on alternate donors such 
as acetyl-CoA or malonyl-CoA should be explored for the 
biosynthesis of additional beneficial products.
Methods
Chemicals
The chemicals used for the S. cerevisiae feeding are 
listed in Additional file  1: Table S1. Rosmarinic acid 
was obtained from Spectrum Chemical Mfg. Corp. 
(New Brunswick, NJ), chlorogenic acid from Alfa Aesar 
(Haverhill, MA), ethyl benzoate, butyl benzoate, isopen-
tyl benzoate and caffeate phenetyl ester from TCI Amer-
ica (Portland, OR), cinnamoyl 3β-tropine and phenethyl 
benzoate from Sigma-Aldrich (St. Louis, MO), and 
coniferyl ferulate from Biorbyt LLC (Berkeley, CA).
Strains, plasmids and media
The vectors pDRf1-4CL5-AtSDT, pDRf1-4CL5-AtSCT, 
pDRf1-4CL5-HvACT, pDRf1-4CL5-OsHCT4, pDRf1-
4CL5-AsFMT, pDRf1-4CL5-EcCS, pDRf1-4CL5-
TpHCT2, pDRf1-4CL5-LaAT1, pDRf1-4CL5-NtHQT, 
pDRf1-4CL5-AtHHT3, and pDRf1-4CL5-BPBT were 
used for co-expression of 4CL5 with the different BAHDs 
under the control of the constitutive promoters PHXT7 
and PPMA1, respectively (Table  1). The Gateway-enabled 
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using a QPix 400 system (Molecular Devices, Sunnyvale, 
CA). Eight colonies per construct were sequence-verified 
using PACBIO RSII system (Pacific Biosciences, Menlo 
Park, CA). Synthesized BAHD sequences and protein 
accession numbers are listed in Additional file 1: Data S1.
For the construct of the pRS423-GW vector, two DNA 
fragments covering the full backbone including PTDH3 
and TCYC1 sequences while excluding XKS1 encoding 
sequence of the pRS423.XI vector were amplified by PCR 
using the oligonucleotide pairs pRS423-fw1/pRS423-rv1 
and pRS423-fw2/pRS423-rv2 (Additional file  1: Table 
S2) and the pRS423.XI vector as a template [72]. A third 
fragment corresponding to the Gateway cassette was 
amplified using the oligonucleotides GW-fw/GW-rv 
(Additional file  1: Table S2) and the pDRf1-4CL5-GW 
vector as a template [13]. The pRS423-GW vector was 
constructed by assembling the three PCR fragments via 
In-Fusion cloning (Clonetech, Mountain View, CA). For 
the construct of the pRS423-FjTAL vector, a nucleotide 
sequence encoding FjTAL (GenBank accession number 
AKE50827.1) flanked with the attB1 (5′-end) and attB2 
(3′-end) Gateway recombination sites was synthesized for 
expression in S. cerevisiae (Genescript, Piscataway, NJ) 
and cloned into the Gateway pDONR221 entry vector by 
BP recombination (Life technologies, Foster City, CA). 
An entry clone was LR recombined with the pRS423-GW 
vector to generate the pRS423-FjTAL construct. Plasmids 
are available upon request through the JBEI-ICE registry 
(http://public-registry.jbei.org) [73].
Production of hydroxycinnamate and benzoate conjugates
Overnight cultures from single colonies of recombinant S. 
cerevisiae harboring the pDRf1-4CL5-BAHDs and pDRf1-
4CL5 [13] constructs were grown using 2X YNB medium 
without amino acids, supplemented with 6% glucose and 
2X CSM-ura. These cultures were used to inoculated 4 mL 
of fresh minimal medium at an OD600 = 0.15 and shaken at 
200 rpm at 30 °C. Precursors were added 5 h post inocula-
tion at the concentrations indicated in Additional file 1: Table 
S1. These concentrations were selected to be below toxicity 
levels and avoid growth inhibition. The cultures were shaken 
at 200 rpm at 30 °C for 24 h in the presence of the precursors 
for the production of hydrocinnamate and benzoate con-
jugates. Yeast colonies harboring the pDRf1-4CL5 control 
Table 1 Plasmids used in this study
Plasmid name Description Reference
pDRf1‑4CL5 URA3 selectable marker, arabidopsis 4CL5
PHXT7‑At4CL5‑TCYC1 (URA3, Amp
R)
[13]
pDRf1‑4CL5‑GW URA3 selectable marker, arabidopsis 4CL5, gateway cloning cassette
PHXT7‑At4CL5‑TCYC1‑PPMA1‑attR1‑Cm
R‑ccdB‑attR2‑TADH1 (URA3, Amp
R)
[13]
pDRf1‑4CL5‑DsRed URA3 selectable marker, arabidopsis 4CL5, DsRed dropout cassette
PHXT7‑At4CL5‑TCYC1‑PPMA1‑DsRed‑TADH1 (URA3, Amp
R)
This work
pRS423‑GW HIS3 selectable marker, Gateway cloning cassette
PTDH3‑attR1‑Cm
R‑ccdB‑attR2‑TCYC1 (HIS3, Amp
R)
This work
pRS423‑FjTAL HIS3 selectable marker, Flavobacterium johnsoniae TAL
PTDH3‑FjTAL‑TCYC1 (HIS3, Amp
R)
This work
pDRf1‑4CL5‑AsFMT URA3 selectable marker, arabidopsis 4CL5, Angelica sinensis FMT
PHXT7‑At4CL5‑TCYC1‑PPMA1‑AsFMT‑TADH1 (URA3, Amp
R)
This work
pDRf1‑4CL5‑AtHHT3 URA3 selectable marker, arabidopsis 4CL5, arabidopsis HHT3
PHXT7‑At4CL5‑TCYC1‑PPMA1‑AtHHT3‑TADH1 (URA3, Amp
R)
This work
pDRf1‑4CL5‑AtSCT URA3 selectable marker, arabidopsis 4CL5, arabidopsis SCT
PHXT7‑At4CL5‑TCYC1‑PPMA1‑AtSCT‑TADH1 (URA3, Amp
R)
This work
pDRf1‑4CL5‑AtSDT URA3 selectable marker, arabidopsis 4CL5, arabidopsis SDT
PHXT7‑At4CL5‑TCYC1‑PPMA1‑AtSDT‑TADH1 (URA3, Amp
R)
This work
pDRf1‑4CL5‑BPBT URA3 selectable marker, arabidopsis 4CL5, Petunia x hybrida BPBT
PHXT7‑At4CL5‑TCYC1‑PPMA1‑BPBT‑TADH1 (URA3, Amp
R)
This work
pDRf1‑4CL5‑EcCS URA3 selectable marker, arabidopsis 4CL5, Erythroxylum coca CS
PHXT7‑At4CL5‑TCYC1‑PPMA1‑EcCS‑TADH1 (URA3, Amp
R)
This work
pDRf1‑4CL5‑HvACT URA3 selectable marker, arabidopsis 4CL5, Hordeum vulgare ACT
PHXT7‑At4CL5‑TCYC1‑PPMA1‑HvACT‑TADH1 (URA3, Amp
R)
This work
pDRf1‑4CL5‑NtHQT URA3 selectable marker, arabidopsis 4CL5, Nicotiana tabacum HQT
PHXT7‑At4CL5‑TCYC1‑PPMA1‑NtHQT‑TADH1 (URA3, Amp
R)
This work
pDRf1‑4CL5‑OsHCT4 URA3 selectable marker, arabidopsis 4CL5, Oryza sativa HCT4
PHXT7‑At4CL5‑TCYC1‑PPMA1‑OsHCT4‑TADH1 (URA3, Amp
R)
This work
pDRf1‑4CL5‑TpHCT2 URA3 selectable marker, arabidopsis 4CL5, Trifolium pratense TpHCT2
PHXT7‑At4CL5‑TCYC1‑PPMA1‑TpHCT2‑TADH1 (URA3, Amp
R)
This work
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vector were grown under similar conditions. Yeast colonies 
co-transformed with the pRS423-FjTAL plasmid and the 
pDRf1-4CL5-LaAT1, pDRf1-4CL5-OsHCT4, pDRf1-4CL5-
AtSCT, pDRf1-4CL5-HvACT, pDRf1-4CL5-TpHCT2, or 
pDRf1-4CL5-AtHHT3 vector were grown under similar 
conditions except that the medium was supplemented with 
2X CSM-ura-his. For the detection of metabolites, an ali-
quot of the culture medium was collected and cleared by 
centrifugation (21,000×g for 5 min at 4 °C), mixed with an 
equal volume of cold methanol:water (1:1, v/v), and filtered 
using Amicon Ultra centrifugal filters (3000 Da MW cutoff 
regenerated cellulose membrane; Millipore, Billerica, MA) 
prior to analysis using high-performance liquid chromatog-
raphy (HPLC), electrospray ionization (ESI), and time-of-
flight (TOF) mass spectrometry (MS). Alternatively, for the 
detection of dodecyl hydroxycinnamates, caffeate phenethyl 
ester and benzoate alcohol esters, the culture medium was 
cleared by centrifugation and mixed with 2 mL of hexane for 
extraction with vortexing. The hexane phase was collected 
after centrifugation and concentrated under a nitrogen 
stream prior to HPLC-TOF-MS analysis. For the detection 
of coniferyl ferulate, yeast cells were harvested by centrifu-
gation, washed and resuspended with 1 mL of HPLC grade 
water, and mixed with 2 mL of hexane for extraction with 
vortexing. The hexane phase was collected after centrifu-
gation and concentrated under a nitrogen stream prior to 
HPLC-ESI-TOF-MS analysis.
LC–MS analysis of hydroxycinnamate and benzoate 
conjugates
Standard solutions of chlorogenic acid, rosmarinic acid, 
coniferyl ferulate and cinnamoyl 3β-tropine were pre-
pared in methanol and water (1:1, v/v) and those of 
caffeate phenethyl ester and benzoate alcohol esters were 
prepared in hexane. All metabolites were separated via 
an Agilent 1200 Series Rapid Resolution high perfor-
mance liquid chromatography (HPLC) system. The sys-
tems autosampler tray was set to 6 °C. The HPLC system 
was coupled to an Agilent Technologies 6210 LC/TOF 
mass spectrometer (MS) via either electrospray ioniza-
tion (ESI) or atmospheric pressure chemical ionization 
(APCI), which was used for MS detection and metabolite 
identification. Drying gas temperature, drying gas pres-
sure, nebulizing gas pressure and capillary voltage were 
set to 330  °C, 10 or 11  L/min, 25  lb/in2, and 3500  V (in 
positive or negative ion modes), respectively, unless stated 
otherwise. For APCI, the vaporizer and corona were set 
to 350 °C and 4 µA, respectively, unless stated otherwise.
A HPLC-ESI-TOF-MS method previously described 
in [12] was used for the separation and detection of ros-
marinic acid and its derivatives, coumaroyl quinate and 
malate hydroxycinnamate esters. The same method was 
used for coniferyl ferulate except that the drying gas 
temperature was set at 200 °C. A similar method was used 
for glycerol hydroxycinnamate esters with the following 
modifications: The mobile phase was composed of water 
(solvent A) and methanol (solvent B), and metabolites 
were separated via gradient elution under the following 
mobile phase compositions: % B was linearly increased 
from 30% B to 98% B in 12 min, held at 98% B for 0.6 min, 
decreased from 98% B to 30% B in 0.2 min and held at 30% 
B for a further 2.8 min. The total run time was 15.6 min. A 
drying gas temperature of 200 °C was used throughout. A 
HPLC-ESI-TOF-MS method previously described in [74] 
was used for the separation and detection of polyamine 
hydroxycinnamates amides and tropane alkaloids.
Separation of benzoate alcohol esters was conducted 
on a Phenomenex Kinetex XB-C18 column (100  mm 
length, 2.1  mm internal diameter, and 2.6  µm particle 
size; Phenomenex, Torrance, CA). The mobile phase was 
composed of water (solvent A) and methanol (solvent 
B). The elution gradient was as follows: % B was linearly 
increased from 60% B to 100% B in 5.0 min, held at 100% 
B for 2.0 min, decreased from 100% B to 60% B in 0.2 min 
and held at 60% B for a further 4.5  min. A flow rate of 
0.3  mL/min was used until 7.0  min, increased from 0.3 
to 0.45 mL/min in 0.2 min and held at 0.45 mL/min for 
4.5  min. The total run time was 11.7  min. The column 
compartment was set to 55 °C. A sample injection volume 
of 2 µL was used throughout. APCI was conducted using 
in the positive ion mode for the detection of [M + H]+ 
ions. The same HPLC column and column compartment 
temperature were used for the separation of CAPE. The 
mobile phase was composed of water (solvent A) and 
acetonitrile (solvent B) and the elution gradient was as 
follows: % B was increased linearly from 25% B to 100% 
B in 3.0 min, held at 100% B for 1.0 min, decreased from 
100% B to 25% B in 0.2 min and held at 25% B for a fur-
ther 4.0  min. A flow rate of 0.3  mL/min was used until 
4.0  min, increased from 0.3 to 0.45  mL/min in 0.2  min 
and held at 0.45 mL/min for the remaining 4.0 min. The 
total run time was 8.2 min. A sample injection volume of 
0.5 µL was used throughout. ESI was conducted in the 
negative ion mode for the detection of [M–H]− ions.
Separation of dodecyl hydroxycinnamates was con-
ducted on a Phenomenex Kinetex XB-C18 column 
(100  mm length, 3.0  mm internal diameter and 2.6  μm 
particle size). A sample injection volume of 3  μL was 
used throughout. The column compartment was set to 
55  °C. The mobile phase was composed of water (sol-
vent A) and methanol (solvent B). The elution gradient 
was as follows: % B was increased linearly from 65% B to 
98% B in 1.47 min, held at 98% B for 9.2 min, decreased 
from 98% B to 65% B in 0.33 min and held at 65% B for 
a further 2.0  min. A flow rate of 0.42  mL/min was used 
until 10.67  min, increased from 0.42 to 0.65  mL/min in 
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0.33 min and held at 0.65 mL/min for 2.0 min. The total 
run time was 13.0 min. APCI was conducted in the pos-
itive ion mode for the detection of [M +  H]+ ions. The 
corona and capillary voltage were set to 15 µA and 3000 V, 
respectively. A nebulizing gas pressure of 30 lb/in2 and a 
drying gas temperature of 200 °C were used throughout.
A HPLC-ESI TOF-MS method was used to detect 
chlorogenic acid. The chromatography was done using a 
Phenomenex Kinetex XB-C18 column (100  mm length, 
3  mm internal diameter and 2.6  µm particle size) using 
the aforementioned HPLC system. A sample injection 
volume of 5 μL was used throughout. The mobile phase 
was composed of 0.1% formic acid in water (solvent A) 
and in methanol (solvent B). The elution gradient was as 
follows: % B was increased linearly from 25 to 77.5% B in 
3.0 min, then increased from 77.5 to 97.1% B in 0.3 min, 
held at 97.1% B for 1.0 min, decreased from 97.1 to 25% 
B in 0.4  min and held at 25% B for a further 2  min. A 
flow rate of 0.42  mL/min was used until 4.3  min, then 
increased from 0.42 to 0.65 mL/min in 0.4 min and held 
at 0.65 mL/min for 2 min. The total run time was 6.7 min. 
The column compartment and sample tray were set to 
50  °C and 6  °C, respectively. A sample injection volume 
of 3 µL was used throughout. ESI was conducted in the 
negative ion mode for the detection of [M–H]− ions. The 
nebulizing gas pressure was set to 30 lb/in2.
Data acquisition and processing were performed by 
the MassHunter software package (Agilent Technologies 
Inc., Santa Clara, CA). For each compound detected, the 
measured masses agreed with the expected theoretical 
masses within less than 5 ppm mass error.
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ammonia‑lyase FjTAL and 4CL5 with LaAT1 (A), OsHCT4 (B), AtSCT (C), 
HvACT (D), TpHCT2 (E) or AtHHT3 (F) were fed with 4‑hydroxyphenyl‑
lactate (A), nothing (B, C), agmatine (D), malate (E) or 1‑dodecanol (F) for 
the synthesis of p‑coumaroyl 4’‑hydroxyphenyllactate (A), p‑coumaroyl 
glycerol (B), N1,N8‑disinapoyl spermidine (C), p‑coumaroyl agmatine 
(D), p‑coumaroyl malate (E) and dodecyl p‑coumarate (F), respectively. 
Figure S2. Synthesis of quinate hydroxycinnamates in yeast. Representa‑
tive LC‑MS chromatograms obtained from analysis of the culture medium 
of a S. cerevisiae strain expressing 4CL5 and NtHQT are shown. The strain 
was fed with quinate and p‑coumarate or caffeate for the synthesis of 
p‑coumaroyl quinate (A) and chlorogenic acid (B), respectively. The LC‑MS 
chromatogram of a solution of authentic chlorogenic acid is also shown 
(C). Table S1. List of acyl acceptors and donors used for the feedings 
of yeast strains expressing 4CL5 and BAHDs. Concentrations used in the 
culture medium are indicated. Table S2. Oligonucleotides used in this 
study. Data S1. Sequence of the red fluorescent protein dropout cassette 
and the codon‑optimized sequences and accession numbers of BAHD 
acyltransferases used in this study.
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